Role of the H19 gene in Syrian hamster embryo cell tumorigenicity

Molecular Carcinogenesis

Volumn 20, Issue 2, 1997, Pages 189-193

  Lsfort, Robert J ^a   Cody, David B ^a   Kerckaert, Gary A ^a   Tycko, Benjamin ^b   LeBoeuf, Robert A ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

H19 gene; SHE cell; Transformation

Indexed keywords

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL TRANSFORMATION; COLONY FORMATION; EMBRYO CELL; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CRICETINAE; EMBRYO; GENE EXPRESSION; MESOCRICETUS; MICE; MICE, NUDE; MUSCLE PROTEINS; RNA, UNTRANSLATED;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS; MUS MUSCULUS;

EID: 0030698256     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199710)20:2<189::AID-MC5>3.0.CO;2-I     Document Type: Article

References (30)

1. Barrett JC, Ts'o POP. Evidence for the progressive nature of neoplastic transformation in vitro. Proc Natl Acad Sci USA 75:3761-3765, 1978.
2. Berwald Y, Sachs L. In vitro transformation with chemical carcinogens. Nature 200:1182-1184, 1963.
3. Berwald Y, Sachs L. In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J Natl Cancer Inst 35:641-661, 1965.
4. Isfort RJ, Cody DB, Doersen C-J, Kerckaert GA, LeBoeuf RA. Alterations in cellular differentiation, mitogenesis, cytoskeleton and growth characteristics during Syrian hamster embryo cell multistep in vitro transformation. Int J Cancer 59:114-125, 1994.
5. LeBoeuf RA, Kerckaert GA, Aardema MJ, Gibson DP. Multistage neoplastic transformation of Syrian hamster embryo cells cultured at pH 6.7. Cancer Res 50:3722-3729, 1990.
6. LeBoeuf R, Kerckaert GA. Enhanced morphological transformation of early passage Syrian hamster embryo cell cultures in medium with a reduced bicarbonate concentration and pH. Carcinogenesis 8:689-697, 1987.
7. Watanabe M, Suzuki K. Expression dynamics of transforming phenotypes in X-irradiated Syrian golden hamster embryo cells. Mutat Res 249:71-80, 1991.
8. Albor A, Flessate DM, Soussi T, Notario V. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation. Cancer Res 54:4502-4507, 1994.
9. Gilmer TM, Annab LA, Barrett JC. Characterization of activated proto-oncogenes in chemically transformed Syrian hamster embryo cells. Mol Carcinog 4:14-24, 1988.
10. Koi M, Barrett JC. Loss of tumor-suppressive function during chemically induced neoplastic progression of Syrian hamster embryo cells. Proc Natl Acad Sci USA 83:5992-5996, 1986.
11. Notario V, Castro R, Flessate DM, Doniger J, DiPaolo JA. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens. Oncogene 5:1425-1430, 1990.
12. Velasco JA, Castro R, Avila MA, et al. cph, a novel oncogene which cooperates with H-ras in the transformation of NIH3T3 fibroblasts. Oncogene 9:2065-2069, 1994.
13. Isfort RJ, Kerckaert GA, LeBoeuf RA. Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals. Mutat Res 356:11-63, 1996.
14. LeBoeuf RA, Kerckaert GA, Aardema MJ, Gibson DP, Brauninger R, Isfort RJ. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals. Mutat Res 356:85-127, 1996.
15. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. Tumor suppressor activity of H19 RNA. Nature 365:764-767, 1993.
16. Isfort RJ, Qian Z, Jones D, Silva RF, Witter R, Kung H-J. Integration of multiple chicken retroviruses into multiple chicken herpesviruses: Herpesviral gD as a common target of integration. Virology 203:125-133, 1994.
17. Zhang Y, Shields T, Crenshaw T, Hao Y, Moulton T, Tycko B. Imprinting of human H19: Allele specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am J Hum Genet 53:113-124, 1993.
18. Isfort RJ, Kerckaert GA, Cody DB, Carter J, Driscoll KE, LeBeouf RA. Isolation and biological characterization of morphological transformation-sensitive Syrian hamster embryo cells. Carcinogenesis 17:997-1005, 1996.
19. Bartolomei MS, Zemel S, Tilghman SM. Parental imprinting of the mouse H19 gene Nature 351:153-155, 1991.
20. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34-39, 1995.
21. Blythe NL, Senior PV, Beck F. Expression of insulin-like growth factor II (IGF-II) and H19 in murine teratocarcinomas derived from embryonic stem (ES) cells. J Anat 188:65-74, 1996.
22. Reeve AE. Role of genomic imprinting in Wilm's tumor and overgrowth disorders. Med Pediatr Oncol 27:470-475, 1996.
23. Morison IM, Becroft DM, Taniguchi T, Woods CG, Reeve AE. Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nat Med 2:311-316, 1996.
24. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci USA 92:2159-2163, 1995.
25. McLaughlin KJ, Szabo P, Haegel H, Mann JR. Mouse embryos with paternal duplication of an imprinted chromosome 7 region die at midgestation and lack placental spongiotrophoblast. Development 122:265-270, 1996.
26. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000, 1987.
27. Pachnis V, Brannan Cl, Tilghman SM. The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J 7:673-681, 1988.
28. Poirier F, Chan C-TJ, Timmons PM, Robertson EJ, Evans MJ, Rigby PWJ. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 113:1105-1114, 1991.
29. Rachmilewitz J, Gileadi O, Eldar-Geva T, Schneider T, deGroot N, Hochberg A. Transcription of the H19 gene in differentiating cytotrophoblasts from human placenta. Mol Reprod Dev 32:196-202, 1992.
30. Wiles MV. Isolation of differentially expressed human cDNA clones: Similarities between mouse and human embryonal carcinoma cell differentiation. Development 104:403-413, 1988.